On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

Image Name

2025.05.10

 

[Suzhou, May 10, 2025] Recently, our company’s Nano Park facility successfully completed the registration process for its P2 laboratory with the Suzhou Municipal Bureau of Agriculture and Rural Affairs, officially becoming one of the first animal pathogen microbiology laboratories in the entire Suzhou metropolitan area to receive official approval under the newly implemented "Jiangsu Province Animal Pathogen Microbiology Laboratory Registration Management Measures" (effective February 1, 2025). This milestone not only highlights our company’s standardized management practices, advanced technical capabilities, and robust biosafety protocols in the field of animal pathogen research but also lays a solid foundation for further enhancing our capacity to deliver cutting-edge scientific services.

According to Jiangsu Province's newly issued "Administrative Measures for the Filing of Animal Pathogen Microbiology Laboratories," any organization conducting experimental activities involving animal pathogen microorganisms must strictly adhere to biosafety standards and complete the filing procedures. Our company's Nanoyuan facility, in accordance with the requirements of these measures, has refined its laboratory management system, optimized its facility and equipment setup, and strengthened staff training and operational protocols—ultimately passing the review process smoothly and successfully obtaining the required filing approval.

The successful completion of this filing not only demonstrates our company's meticulous approach to biosafety and compliant operations, but also provides the necessary qualifications to further advance high-level research related to animal-pathogenic microorganisms. Moving forward, we will continue to uphold stringent standards and exacting requirements, contributing to the development of regional biopharmaceuticals and agricultural science while fostering technological progress across the industry.

 

West Mountain

Previous article

None

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

Next article

Previous article

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

Next article

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

More information

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

[Suzhou, May 10, 2025] Recently, our company’s Nano Park facility successfully completed the filing process for its P2 laboratory with the Suzhou Municipal Bureau of Agriculture and Rural Affairs, officially becoming one of the first animal pathogen microbiology laboratories in the entire Suzhou metropolitan area to receive approval under the newly implemented "Jiangsu Province Animal Pathogen Microbiology Laboratory Filing Management Measures" (effective February 1, 2025).

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

Recently, our company successfully passed the on-site expansion review for CMA accreditation, marking official recognition from a national authority of our professional expertise and robust quality management system in the field of laboratory animal testing. The review took place from September 1 to September 2, 2024, during which the expert panel conducted a comprehensive and rigorous assessment of our laboratory animal testing technologies, equipment, personnel, and management systems—ultimately confirming that we meet the relevant CMA standards.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024 – Our company has officially obtained the Veterinary Drug Production License and the Veterinary Drug GMP Certificate issued by the Ministry of Agriculture and Rural Affairs, marking that our company’s quality management system and technical capabilities in the veterinary drug manufacturing sector have met the nation’s stringent high-standard requirements. During this certification process, our immunology-based diagnostic product (Class B) production line successfully passed the on-site GMP inspection for veterinary drugs and was recognized as a qualified production line, laying a solid foundation for the company to further expand into the veterinary diagnostic reagent market.